DEPERSONALIZATION-DEREALIZATION DISORDER WITH ACUTE AND PROGRESSIVE ONSET: COMPARISON OF CLINICAL CASES

Authors

DOI:

https://doi.org/10.32689/2663-0672-2022-1-3

Keywords:

psychiatry, medical psychology, psychotrauma, depersonalization, derealization, dissociation.

Abstract

Abstract. Introduction. The prevalence of depersonalization-derealization disorder (DDD) among psychiatric patients determines the relevance of the research topic. Analysis of recent research and publications. The pathophysiological mechanism of depersonalization still remains unclear. The triggering mechanism for the development of depersonalization-derealization disorder can be: psychotraumatic events, the effect of psychoactive substances, the effect of medications, the development of another mental illness, etc. In some cases, the disease begins acutely, in others, the symptoms gradually increase. Patients with ADHD are prone to excessive self-reflection with compulsive scanning of their feelings. As psychological defense mechanisms, such stress-coping strategies as social isolation, self-blame, and rumination are characteristic of them. Formulation of the problem. The phenomenon of depersonalization is a “negative” symptom”, therefore, for the patient, it is difficult to verbalize and explain, which makes it difficult to detect it in patients in a timely manner and carry out qualitative differential diagnosis. Formulation of the purpose of the research. The goal is to carefully study cases of DDR in individual patients in order to improve diagnostics and therapeutic approaches for these disorders. Research materials and methods. Analytical, clinical, clinical-psychopathological, pathopsychological, psychodiagnostic, comparative methods were used in the research. A block of psychometric scales was used to psychometrically assess the condition of the patients: the Hamilton Anxiety Assessment Scale (HAM-A), the Beck Hopelessness Scale (BHI), the Sheehan Anxiety Self- Assessment Scale (SPRAS), the Cambridge Depersonalization Questionnaire (CDS), the Dissociation Scale (DES), the test of sensolife orientations in Leontiev’s adaptation (SZHO), the Big Five Inventory test. Research results. Despite the differences in etiological factors, the pathogenetic mechanism of DDR development was common in both clinical cases. The use of a combination of escitalopram and lamotrigine produced significant improvement for both patients, but without complete reduction of symptoms. Conclusions and prospects for further research. Differences in the etiological factors of the development of DDR were revealed, but the similarity of the pathogenetic mechanism of development, which should be taken into account when determining the strategy of complex treatment of patients with the use of psychopharmacotherapy and psychotherapeutic intervention to increase its effectiveness. The lack of a clear view of the neurobiological and neurochemical processes underlying ADHD requires further study of the pathogenetic mechanisms of these disorders.

References

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). 2013. doi: 10. 1176/appi. books.9780890425596

Baker D, Hunter E, Lawrence E, et al: Depersonalisation disorder: clinical features of 204 cases. Br J Psychiatry 2003; 182: 428–433.

Bout A, Berhili N, Benbrahim M, Aalouane R & Rammouz I. Trouble de dépersonnalisation/déréalisation résistant et lamotrigine: à propos d’un cas. L’Encéphale. 2018. 44(1). 85–87. doi:10.1016/j.encep.2017.04.003

Choi KR, Seng JS, Briggs EC, Munro-Kramer ML, Graham-Bermann SA, Lee RC, Ford JD. The Dissociative Subtype of Posttraumatic Stress Disorder (PTSD) Among Adolescents: Co-Occurring PTSD, Depersonalization/Derealization, and Other Dissociation Symptoms. J Am Acad Child Adolesc Psychiatry. 2017. 56(12). 1062–1072. doi: 10.1016/j.jaac.2017.09.425

Ciaunica A, Roepstorff A, Fotopoulou AK, Petreca B. Whatever Next and Close to My Self-The Transparent Senses and the “Second Skin”: Implications for the Case of Depersonalization. Front Psychol. 2021 May 31. 12. 613587. doi: 10.3389/ fpsyg.2021.613587

Cohen PR. Medication associated depersonalization symptoms: a report of transient depersonalization symptoms induced by minocycline. South Med J. 2004. 97. 70–73.

Foote B, Smolin Y, Kaplan M, Legatt ME, Lipschitz D. Prevalence of dissociative disorders in psychiatric outpatients. Am J Psychiatry. 2006. 356:623-9. doi: 10.1176/ajp.2006.163.4.623

French NJ, Eberle JW, Teachman BA. Anxiety sensitivity, distress intolerance, and negative interpretation bias strengthen the relationship between trait anxiety and depersonalization. Anxiety Stress Coping. 2021. 1–14. doi: 10.1080/10615806.2021.1977797

Hunter EC, Sierra M, David AS. The epidemiology of depersonalisation and derealisation. A systematic review. Soc Psychiatry Psychiatr Epidemiol. 2004. 3. 9–18.

Karris BC, Capobianco M, Wei X, Ross L. Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation. J Psychiatr Pract. 2017. 23(2). 141–144. doi: 10.1097/PRA.0000000000000215

Mancini-Marïe A, Fahim C, Potvin S, Beauregard M & Stip E. Quetiapine: focus on emotional numbing in depersonalization disorder: an fMRI case report. European Psychiatry. 2006. 21(8). 574–577. doi:10.1016/j.eurpsy.2005.05.014

Rosagro-Escámez M, Koechel A, Canterino M, Adler J, Reiner I, Vossel G, Beutel ME, Gamer M. Depersonalization disorder: disconnection of cognitive evaluation from autonomic responses to emotional stimuli. PLoS One. 2013 Sep 13. 8(9). e74331. doi: 10.1371/journal.pone.0074331 ; PMID: 24058547 ; PMCID: PMC3772934

Michal M, Wiltink J, Subic-Wrana C, Zwerenz R, Tuin I, Lichy M, Beutel ME. Prevalence, Correlates, and Predictors of Depersonalization Experiences in the German General Population. J Nerv Ment Dis. 2009. 197(7). 499–506. doi: 10.1097/ nmd.0b013e3181aacd94

Michal M, Adler J, Wiltink J, Reiner I, Tschan R, Wölfling K, Weimert S, Tuin I, Subic-Wrana C, Beutel ME and Zwerenz R. BMC Psychiatry. 2016. 16:203. doi:10.1186/s12888-016-0908-4

Owens AP, David AS, Low DA, Mathias CJ, Sierra-Siegert M. Abnormal cardiovascular sympathetic and parasympathetic responses to physical and emotional stimuli in depersonalization disorder. Front Neurosci. 2015 Mar 26; 9. 89. doi: 10.3389/ fnins.2015.00089 ; PMID: 25859177 ; PMCID: PMC4374468

Pikwer A. Depersonalization disorder may be related to glutamate receptor activation imbalance. Med Hypotheses. 2011. 77(4). 593–4. doi: 10.1016/j.mehy.2011.06.041

Preve M, Mula M, Cassano GB & Pini S. Venlafaxine in somatopsychic and autopsychic depersonalization. Neuro- Psychopharmacol. Biol. Psychiatry. 2011. 35(8). 1808–1809. doi:10.1016/j.pnpbp.2011.06.011

Rachid F. Treatment of a Patient With Depersonalization Disorder With Low Frequency Repetitive Transcranial Magnetic Stimulation of the Right Temporo-Parietal Junction in a Private Practice Setting. J Psychiatr Pract. 2017. 23(2). 145–147. doi:10.1097/PRA.0000000000000214

Rosagro-Escámez F, Gutiérrez-Fernández N, Gómez-Merino P, de la Vega I, Carrasco JL. The efficacy of lamotrigine in a resistant case of depersonalization disorder. Actas Esp Psiquiatr. 2011. 39(4). 263–6.

Sachdev P.Citalopram-Clonazepam combination for primary depersonalizationdisorder: a case report. Aust NZ J Psychiat. 2002. 36(3). 424–425. doi:10.1046/j.1440-1614.2001.t01-1-01030.x

Salgado A, Oliveira L, Sierra-Siegert M & Salgado JV. Depersonalization and Derealization Syndrome: Report on a Case Study and Pharmacological Management. Revista Brasileira de Psiquiatria. 2012. 34(4). 505–508. doi:10.1016/j.rbp.2012.04.006

Shamout Y, Sigal A & Litvinov IV Minocycline-induced transient depersonalization: A case report. SAGE Open Medical Case Reports. 2019. 7. 2050313X1882382. doi:10.1177/2050313x18823827

Sierra M, Baker D, Medford N & David AS. Unpacking the depersonalization syndrome: An exploratory factor analysis on the Cambridge Depersonalization Scale. Psychol. Med. 2005. 35. 1523–1532. doi:10.1017/S0033291705005235

Sierra M, Baker D, Medford N, Lawrence E, Patel M, Phillips ML, David AS. Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases. Clin Neuropharmacol. 2006. 29(5). 253–8. doi: 10.1097/01. WNF.0000228368.17970.DA

Sierra M, Berrios GE. Depersonalization: neurobiological perspectives. Biol. Psychiatry. 1998. Vol 44(9). 898–908. DOI: 10.1016/S0006-3223(98)00015-8

Sierra M, Phillips ML, Ivin G, Krystal J, David AS. A placebo-controlled, Crossover trial of lamotrigine in depersonalization disorder. J Psychopharmacol. 2003. 17. 103–5.

Simeon D, Knutelska M. The role of fearful attachment in depersonalization disorder. Eur. J. Trauma, 2022. doi: 10.1016/j. ejtd.2022.100266.

Simeon D, Knutelska M, Nelson D, Guralnik O. Feeling unreal: a depersonalization disorder update of 117 cases. J Clin Psychiatry. 2003. 64. 990–997.

Stein DJ., Koenen KC, Friedman MJ, Hill E, McLaughlin KA., Petukhova M, Kessler RC. Dissociation in Posttraumatic Stress Disorder: Evidence from the World Mental Health Surveys. Biol. Psychiatry. 2013. 73(4). 302–312. doi:10.1016/j.biopsych.2012.08.02

Tanaka S. What is it Like to Be Disconnected from the Body?: A Phenomenological Account of Disembodiment in Depersonalization/ Derealization Disorder. J. Conscious. Stud. 2018. 25(5–6). 239–262.

Weber JV, Frizzell W, Bullard KA & Chien J. Resolution of Acute-Onset Depersonalization/Derealization With Clonazepam and Inpatient Hospitalization. J. Clin. Psychopharmacol. 2018. 38(3). 272–273. doi:10.1097/jcp.0000000000000869

Wolfradt U & Engelmann S. Depersonalization, fantasies, and coping behavior in clinical context. J. Clin. Psychol. 2003. 59. 1117–1124. doi: 10.1002/jclp.10204

World Health Organization. International classification of diseases for mortality and morbidity statistics (11th revision). 2018. https://icd.who.int/browse11/l-m/en

Published

2022-12-07

How to Cite

КОБЗАР, О., & ПИЛЯГІНА, Г. (2022). DEPERSONALIZATION-DEREALIZATION DISORDER WITH ACUTE AND PROGRESSIVE ONSET: COMPARISON OF CLINICAL CASES. Modern Medicine, Pharmacy and Psychological Health, (1(8), 23-31. https://doi.org/10.32689/2663-0672-2022-1-3